They are more than likely taking a break and have more important...

They are more than likely taking a break and have more important issues to deal with.
Calling them pumpers is a bit rich, all they did was give their opinions and back it up with company information not widely known.
Things have certainly taken a downward trend along with the shareprice, I have put more posters on ignore the last few weeks than I have for a couple of years.
The sharks smell blood in the water and whatever their motives may be it does impact those with a positive message.
Nothing has been announced that could be seen as a negative, with some data updates to be provided over the next 2-3 months.
We have not seen anything from the market relating to the ODD for Vaxinia, and this will give that drug the best chance of success, and protection from competition for 7 years, plus potential grant funding.
Azer-cel is looking very positive on small numbers, particularly with the IL2 protien at very small doses, and this in patients that have endured at least 5-6 prior treatments that had failed so to get even 1 CR let alone 3 is outstanding and with very high safety.
We are yet to hear of the RenovoRX collaboration, the PD1-Vaxx, Neo-Polem trial for colerectal cancer in the UK and Australia to begin soon as first line treatment and finally the OASIS trial with OnCARlytics in early stages.
I would think knowing all this, and to sell at 5c is tantamount to madness, but who am I to tell anyone what they should be doing, do as you must and the best of luck to you all.
I will wait for the impending news which at the very least is bound to produce a re-rate for this extremely promising Company and it's talented management.

DYOR opinion only